Mosaic Company (the) · NYSE:MOS
Mosaic Company (the) — The Mosaic Company — Investor Day (March 2021)
19 slides from Mosaic Company (the)'s investor day presentation, Mar 11, 2021
Slide 1: Optimizing Operating Assets & Capital Management
Optimizing Operating Assets Capital Management Chapter 4 Presenters: Joc O’Rourke, CEO & Clint Freeland, CFO Date: March 11, 2021 1
Slide 2: Forward Looking Statements & Non-GAAP Financial Measures
Forward Looking Statements & Non-GAAP Financial Measures This document contains forward-looking statements w ithin the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about proposed or pending future transactions or strateg
Slide 3: Mosaic's Strategic Priorities
Mosaic’s Strategic Priorities North America Drive Functional Transformation Collaboration and Efficiency Uncover and pursue new opportunities to improve the profitability and Rethink and re-engineer outdated and inefficient processes, and competitiveness of our Potash and Phosphates businesses conti
Slide 4: 2020 results versus 2019
2020 2019 Net Income $666M ($1.07B) +162% Adjusted EBITDA* $1.56B $1.41B +11% Adjusted Operating Earnings* $734M $460M +60% Consolidated Gross Margin $1,065M $897M +19% MOP Selling Price $181 $237 DAP Selling Price $310 $325 * See “Non-GAAP Financial Measures” for additional information and reconcil
Slide 5: North America Transformation
North America Transformation Drive Functional Collaboration and Efficiency • Transformation delivering production, cost and other operational records across the business • Integrated Operations Center in Phosphates is operational • Esterhazy K3 acceleration on track to be fully operational by mid-20
Slide 6: South America Growth Engine
South America Growth Engine • Record-setting financial results • Ahead of schedule to achieve transformation targets • Expect continued growth on many fronts with strong grower economics and well positioned distribution business 6
Slide 7: Grow and Strengthen Our Product Portfolio; Act Responsibly
Grow and Strengthen Our Product Portfolio Act Responsibly SOIL HEALTH Record setting Mosaic: 2020 Promising new growth in 2020 of Award Winner MicroEssentials ® and partnerships: 4 million tonnes, The Campbell Award Sus-Terra™ fertilizer by • Bio-Consortia with 2023 target of recognizes leadership T
Slide 8: Consolidated Adjusted EBITDA Growth
Consolidated Adjusted EBITDA* Growth $ in millions Expected Increase in EBITDA* from Identified Initiatives $1,000 $900 $800 ~$700 $700 ~$600 $600 Other $500 ~$440 Phosphates $400 ~$318 Potash $300 Mosaic Fertilizantes $200 $100 $0 2020 2021 2022 2023 Full Year 2020 Transformational Benefits P K MF
Slide 9: Expected Capital Expenditures Over Time
Expected Capital Expenditures Over Time ~$1.1 billion Reserve Extension/Other ~$800 million Growth 2021 is the highwater mark for Sustaining total capex. Total spending should decline from here. 2021 2025 9
Slide 10: Expected FCF Growth Before Market Impact
Expected FCF Growth Before Market Impact $ in millions $ in millions $1,000 $800 $600 Change in Total Capex/ARO Spend $400 Non-Market EBITDA Growth $200 $0 -$200 2021 2022 2023 * Relative to the 2019 base year 10
Slide 11: Mosaic's Market Sensitivities
Mosaic’s Market Sensitivities Sensitivity Full year adj. EBITDA impact(1) 2020 Actual Average MOP Price / tonne (fob mine)(3) $10/mt price change = $65 million (2) $181 Average DAP Price / tonne (fob plant)(3) $10/mt price change = $105 million $310 Average BRL / USD 0.10 change, unhedged = $13 mill
Slide 12: Brazilian Currency and Inflation Offsets
Brazilian Currency and Inflation Offsets Brazilian inflation has accelerated, offsetting some of the benefits of currency depreciation. FX IPCA IBRL/USD v Inflation Inflation Exposed Local Currency Costs 60.00 14.00 ~BRL 4 billion 50.00 12.00 2021 IPCA Market Consensus = 3.7% 40.00 IPCA* 2020 Inflat
Slide 13: Capital Allocation
Capital Allocation 13
Slide 14: Our Capital Allocation Goals
Our Capital Allocation Goals • Lower Debt by $1 billion over time Strengthen the • Maintain At Least Baa/BBB Credit Balance Sheet Metrics Through the Cycle • Focus on High-Return Projects Invest in the • Improve Competitive Positioning Competition Business • Opportunistic M&A For Capital • Provide a
Slide 15: Leverage Through the Cycle
Leverage Through the Cycle Using YE 2020 net debt of $4.1 billion, debt to trailing EBITDA* ranges from ~1.2 times at peak to ~4.2 times at trough 4.5x 4.0x Actual 3.5x 3.0x 2.5x 2.0x 1.5x Assumes $1 billion less in total debt 1.0x 0.5x 0.0x 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 * See “N
Slide 16: How Mosaic Has Allocated Capital
How Mosaic Has Allocated Capital Strengthen the • Repaid ~$800 million of long-term debt over last 3 years Balance Sheet • Allocated ~$485 million in capital to drive $700 million in EBITDA Invest in the growth in 2020 to 2023, with $325 million of that investment in K3 Business • Indicative returns
Slide 17: Near-Term Uses of Cash
Near-Term Uses of Cash Shareholder Debt Reduction Invest in the Return Business $450MM Increase annual dividend Growth/Transformation from $0.20/share to (Nov '21 bond maturity) 0.30/share First step in goal of $1BN $300MM $114MM debt reduction Future Flexibility Expected cash build will allow Mosai
Slide 18: Slide 18
Slide 19: Reconciliation of non GAAP measures
Reconciliation of non GAAP measures Consolidated Earnings (Loss) (in millions) 2020 2019 Consolidated net earnings (loss) attributable to Mosaic $666 $(1,067) Less: Consolidated interest expense, net (180) (183) Plus: Consolidated depreciation, depletion and 846 883 amortization Plus: Accretion expe